Internal Medicine Doctors in Dracut, MA Accepting Medicare

6 Internal Medicine doctors found. Showing 1 - 6

Miguel A Ariza, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9 Loon Hill Rd Ste 301, Dracut, MA 01826 Phone: 978-323-0360    Fax: 978-323-0362

Dr. Anca Staii, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9 Loon Hill Rd Ste 301, Dracut, MA 01826 Phone: 978-323-0360    Fax: 978-323-5303

Dr. Smita C Chaudhari, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 Nashua Rd Ste 8, Dracut, MA 01826 Phone: 978-957-4474    Fax: 603-577-5644

Dr. Carlos Angel Del Rio, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 Nashua Rd, Suite 1, Dracut, MA 01826 Phone: 978-957-9650    Fax: 978-957-9017

Dr. Hayward Keith Zwerling, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9 Loon Hill Rd Ste 300, Dracut, MA 01826 Phone: 978-323-0360    Fax: 978-323-0362

Richard V Miron, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 505 Nashua Rd 7, Dracut, MA 01826 Phone: 978-674-0271    Fax: 978-674-0279

News Archive

Patients with Phenylketonuria face increased risk of developing severe neurological complications

Genetic researchers at Children's Memorial Hospital, Chicago, are aggressively identifying adult patients who suffer from the genetic disorder, Phenylketonuria (PKU), and are presenting those findings at the 11th International Congress of Inborn Errors of Metabolism in San Diego, August 29 through September 2.

Convergence enters drug discovery collaboration with Selcia for chronic pain treatment

Convergence Pharmaceuticals Limited, the new company focused on the development of novel and high value analgesic medicines, and Selcia Limited, a contract research organisation, today are pleased to announce that they have entered into a drug discovery collaboration to identify and develop high quality candidate molecules for the treatment of chronic pain.

Keryx KRX-0401 trial data against colorectal cancer, multiple myeloma to be presented at AACR

Keryx Biopharmaceuticals, Inc. today announced that two abstracts on KRX-0401 will be presented at the upcoming 102nd annual meeting of the American Association for Cancer Research to be held in Orlando, Florida, from April 2-6, 2011.

Integrating rapid syphilis and HIV testing for pregnant women could reduce maternal, child morbidity and mortality

"A study conducted in Uganda and Zambia by the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) found high rates of syphilis and HIV co-infection among pregnant women in both countries," but showed that "integrating rapid syphilis screening and HIV testing for pregnant women was feasible, cost-effective, and helped to prevent transmission of syphilis and HIV from mother-to-child," PlusNews reports.

AdvanDx receives FDA clearance for its 90 minutes PNA FISH protocol

AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its E. coli/P. aeruginosa PNA FISH® and EK/P. aeruginosa PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.

Read more Medical News

› Verified 9 days ago